1. Bobrow RS. Benzodiazepines revisited. Family Practice 2003; 20:347–349.
2. Clinical guidelines for the use of benzodiazepines among patients receiving medication – assisted treatment for opioid dependence. Baltimore Substance Abuse Systems, Inc. May 2013 http://www.bhsbaltimore.org/site/wp-content/uploads/2013/09/Benzo-Guidelines-FINAL-May-2013.pdf
3. Kostowski W, Herman Z. Farmakologia. Podstawy farmakoterapii. PZWL. Warszawa 2010.
4. Sobów T. Benzodiazepiny u pacjentów w podeszłym wieku. Medycyna Wieku Podeszłego 2012; 2(1): 1-6.
5. Bostwick JR, Casher MI, Yasugi S. Benzodiazepines: A versatile clinical tool. Curr Psychiatr 2012; 11(4): 55-63.
6. Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological
treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - first revision. World J Biol Psychiatry.2008;9(4):248-312.
7. Ballenger JC, Davidson JR, Lecrubier Y, et al. Consensus statement update on posttraumatic stress disorder from the international
consensus group on depression and anxiety. J Clin Psychiatry. 2004;65(suppl 1):55-62.
8. A consensus statement on the use of benzodiazepines in specialist mental health services. EAP 03/2012 Position Paper. College of Psychiatry of Ireland June 2012.
9. Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487-504.
10. Ashton H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs. 1994 Jul;48(1):25-40. www.
benzo.org.uk
11. Mehdi T. Benzodiazepines revisited. BJMP 2012;5(1):a501. http://www.bjmp.org/content/benzodiazepines-revisited
12. Guidelines for the use of benzodiazepines in office practice in the state of Maine. http://www.benzos.une.edu/documents/prescribingguidelines3-26-08.pdf
13. Wheatley, D. Effects of drugs on sleep. In Psychopharmacology of sleep. Wheatley D, ed. New York: Raven Press, 1981; 153-176.
14. Lader, M. The present status of benzodiazepines and psychiatry and medicine. Drug Res 1980; 30:910-913.
15. Rickels, K. Use of anti-anxiety drugs and anxious outpatients. Psychopharmacology 1978; 58:1-17.
16. Greenblatt, D.J & Shader RI: Benzodiazepines in Clinical Practice. New York, Raven Press, 1974.
17. Hidalgo RB, Tupler LA, Davidson JR. An effect-size analysis of pharmacologic treatments of generalized anxiety disorder. J Psychopharmacol.
2007;21(8):864-872.
18. Pollack MH, Simon NM, Worthington JJ, et al. Combined paroxetine and clonazepam treatment strategies compared to paroxetine
monotherapy for panic disorder. J Psychopharmacol. 2003;17(3):276-282.
19. Otto MW, McHugh RK, Simon NM, et al. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: further evaluation. Behav Res Ther. 2010;48(8):720-727.
20. Davidson JR. Use of benzodiazepines in social anxiety disorder generalized anxiety disorder, and posttraumatic stress disorder. J Clin Psychiatry. 2004;65(suppl 5):29-33.
21. Connor KM, Davidson JR, Potts NL, et al. Discontinuation of clonazepam in the treatment of social phobia. J Clin Psychopharmacol.
1998;18(5):373-378.
22. Melton ST, Kirkwood CK. Anxiety disorders I: generalized anxiety panic, and social anxiety disorders. In: DiPiro JT, Talbert RL, Yee
GC, et al, eds. Pharmacotherapy: a pathophysiologic approach. New York, NY: McGraw-Hill Companies; 2011:1209-1228.
23. Menon SJ. Psychotropic medication during pregnancy and lactation.
Arch Gynecol Obstet. 2008;277(1):1-13.
24. Benzodiazepines. Good practice guidelines for clinicians. National Documentation Centre on Drug Use. Ireland. http://www.drugsandalcohol. ie/5349/1/1500-1388.pdf
25. Makowska I. Farmakoterapia bezsenności. Lek w Polsce. 2014; 276(4): 14-20.
26. Heffron WA., Roth P., Double-blind evaluation of the safety and hypnotic efficacy of temazepam in insomniac outpatients. Br J Clin
Pharmacol 1979; 8(Suppl 1): 69S–72S.
27. Luks AM. Which medications are safe and effective for improving sleep at high altitude? High Alt Med Biol. 2008 Fall;9(3):195-8.
28. Agarwal V, Kommaddi RP, Valli K, i wsp. Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and
metabolism of anti-anxiety drug alprazolam to its active metabolite. PLoS One. 2008 Jun 11;3(6):e2337.
29. Mendelson WB. Medications in the treatment of sleep disorders. In: Meltzer HY, editor. Psychopharmacology: the third generation of
progress. New York: Raven Press. 1987: 1305-11.
30. Lader M. Avoiding long-term use of benzodiazepine drugs;. Prescriber March 1991; 79-83.
31. Morawiec S. Leczenie zaburzeń lękowych. Gabinet Prywatny 2014; 233(1): 51-61.